During the past decade, Grand View - Lehigh Valley Health Services, Buxmont Cardiology Division conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Grand View - Lehigh Valley Health Services, Buxmont Cardiology Division" are "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Grand View - Lehigh Valley Health Services, Buxmont Cardiology Division" in a lesser frequency.

Most popular intervention types in "Grand View - Lehigh Valley Health Services, Buxmont Cardiology Division" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Grand View - Lehigh Valley Health Services, Buxmont Cardiology Division" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Grand View - Lehigh Valley Health Services, Buxmont Cardiology Division". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Grand View - Lehigh Valley Health Services, Buxmont Cardiology Division, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Grand View - Lehigh Valley Health Services, Buxmont Cardiology Division, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".